Cyfuse Biomedical K.K. 4892Short Interest
Estimated short interest in Cyfuse Biomedical K.K. (4892) is 6.93% of shares outstanding as of 2026-08-17. Institutions holding 0.5% or more: BNP Paribas Arbitrage SNC, BNP Paribas Financial Markets formerly known as BNP Paribas Arbitrage SNC.
Estimated short interest
6.93%
▼0.01%
Estimated position (shares)
612,200
As of 2026-08-17
Short sellers
13 firms
1357 reports
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest, stacking the latest reported position of each short seller. The 5 largest current holders are shown in color and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- BNP Paribas Arbitrage SNC
- BNP Paribas Financial Markets formerly known as BNP Paribas Arbitrage SNC
- UBS AG
- Barclays Capital Securities Ltd
- BNP Paribas Financial Markets SNC
- Others
6.93%
Estimated short interest, 2026-08-17
Others3.66%
BNP Paribas Financial Markets SNC0.49%
Barclays Capital Securities Ltd0.49%
UBS AG0.49%
BNP Paribas Financial Markets formerly known as BNP Paribas Arbitrage SNC0.84%
BNP Paribas Arbitrage SNC0.96%
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2023-12-06 | BNP Paribas Arbitrage SNC | Position 75,400 shares | Ratio 0.96% | ▼0.13% | Holding |
| 2023-12-11 | BNP Paribas Financial Markets formerly known as BNP Paribas Arbitrage SNC | Position 66,200 shares | Ratio 0.84% | ▼0.12% | Holding |
| 2026-08-17 | UBS AG | Position 49,600 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-07-17 | Barclays Capital Securities Ltd | Position 49,500 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2023-12-19 | BNP Paribas Financial Markets SNC formerly known as BNP Paribas Arbitrage SNC | Position 39,000 shares | Ratio 0.49% | ▼0.10% | Below 0.5% |
| 2025-03-05 | Pi Radians Capital Inc. | Position 40,200 shares | Ratio 0.49% | ▼0.04% | Below 0.5% |
| 2025-05-16 | BNP Paribas Financial Markets SNC | Position 41,500 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2025-04-04 | Citigroup Global Markets Limited | Position 39,800 shares | Ratio 0.48% | ▼0.03% | Below 0.5% |
| 2025-06-10 | MERRILL LYNCH INTERNATIONAL | Position 39,700 shares | Ratio 0.47% | ▼0.03% | Below 0.5% |
| 2025-08-26 | JPM Securities Japan Co Ltd. | Position 43,500 shares | Ratio 0.47% | ▼0.12% | Below 0.5% |
| 2026-06-08 | GOLDMAN SACHS INTERNATIONAL | Position 47,100 shares | Ratio 0.46% | ▼0.13% | Below 0.5% |
| 2026-06-18 | Nomura International plc | Position 45,300 shares | Ratio 0.44% | ▼0.10% | Below 0.5% |
| 2025-12-26 | Morgan Stanley MUFG Securities Co., Ltd. | Position 35,400 shares | Ratio 0.36% | ▼0.14% | Below 0.5% |
Disclosure History 1357 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-08-17 | UBS AG | Position 49,600 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-07-21 | UBS AG | Position 51,200 shares | Ratio 0.50% | ▲0.01% | — |
| 2026-07-17 | Barclays Capital Securities Ltd | Position 49,500 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2026-07-16 | Barclays Capital Securities Ltd | Position 51,500 shares | Ratio 0.51% | ▲0.02% | — |
| 2026-07-08 | Barclays Capital Securities Ltd | Position 50,300 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-07-07 | Barclays Capital Securities Ltd | Position 50,900 shares | Ratio 0.50% | ▲0.03% | — |
| 2026-07-02 | Barclays Capital Securities Ltd | Position 47,600 shares | Ratio 0.47% | ▼0.03% | Below 0.5% |
| 2026-06-24 | UBS AG | Position 50,300 shares | Ratio 0.49% | ▼0.09% | Below 0.5% |
| 2026-06-24 | Barclays Capital Securities Ltd | Position 50,600 shares | Ratio 0.50% | ▲0.03% | — |
| 2026-06-22 | Barclays Capital Securities Ltd | Position 48,300 shares | Ratio 0.47% | ▼0.05% | Below 0.5% |
| 2026-06-19 | Barclays Capital Securities Ltd | Position 52,500 shares | Ratio 0.52% | ▲0.10% | — |
| 2026-06-18 | Nomura International plc | Position 45,300 shares | Ratio 0.44% | ▼0.10% | Below 0.5% |
| 2026-06-12 | Nomura International plc | Position 54,700 shares | Ratio 0.54% | ▼0.06% | — |
| 2026-06-09 | UBS AG | Position 58,800 shares | Ratio 0.58% | ▼0.02% | — |
| 2026-06-08 | Nomura International plc | Position 60,600 shares | Ratio 0.60% | ▲0.11% | — |
| 2026-06-08 | GOLDMAN SACHS INTERNATIONAL | Position 47,100 shares | Ratio 0.46% | ▼0.13% | Below 0.5% |
| 2026-06-05 | UBS AG | Position 60,600 shares | Ratio 0.60% | ▲0.01% | — |
| 2026-06-05 | Nomura International plc | Position 49,566 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2026-06-04 | UBS AG | Position 60,500 shares | Ratio 0.59% | ▼0.01% | — |
| 2026-06-03 | UBS AG | Position 60,800 shares | Ratio 0.60% | ▲0.03% | — |
| 2026-06-03 | Nomura International plc | Position 51,600 shares | Ratio 0.51% | ▼0.14% | — |
| 2026-06-02 | Nomura International plc | Position 65,865 shares | Ratio 0.65% | ▲0.09% | — |
| 2026-05-29 | Nomura International plc | Position 56,800 shares | Ratio 0.56% | ▼0.07% | — |
| 2026-05-28 | Nomura International plc | Position 63,600 shares | Ratio 0.63% | ▲0.05% | — |
| 2026-05-26 | Nomura International plc | Position 58,700 shares | Ratio 0.58% | ▲0.11% | — |
| 2026-05-26 | GOLDMAN SACHS INTERNATIONAL | Position 60,000 shares | Ratio 0.59% | ▼0.07% | — |
| 2026-05-21 | Nomura International plc | Position 47,400 shares | Ratio 0.46% | ▼0.13% | Below 0.5% |
| 2026-05-20 | UBS AG | Position 58,100 shares | Ratio 0.57% | ▲0.16% | — |
| 2026-05-20 | Nomura International plc | Position 60,000 shares | Ratio 0.59% | ▲0.20% | — |
| 2026-05-18 | Nomura International plc | Position 46,200 shares | Ratio 0.45% | ▼0.06% | Below 0.5% |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| GNI Group Ltd.2160 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kyowa Kirin Co.,Ltd.4151 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Takeda Pharmaceutical Company Limited4502 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Core30 |
| Astellas Pharma Inc.4503 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| Sumitomo Pharma Co.,Ltd.4506 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |